603087Gan & Lee Pharmaceuticals603087 info
$5.41info0.60%24h
Global rank3814
Market cap$3.21B
Change 7d-2.15%
YTD Performance-26.88%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Gan & Lee Pharmaceuticals (603087) Stock Overview

    Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company's products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection. It also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

    603087 Stock Information

    Symbol
    603087
    Address
    No. 8, Nanfeng West 1st StreetBeijing, 101109China
    Founded
    -
    Trading hours
    9:30 AM - 3:00 PM CST
    Website
    https://www.ganlee.com
    Country
    🇨🇳 China
    Phone Number
    86 10 8059 3699

    Gan & Lee Pharmaceuticals (603087) Price Chart

    -
    Value:-

    Gan & Lee Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $5.41
    N/A
    Market Cap
    $3.21B
    N/A
    Shares Outstanding
    594.16M
    N/A
    Employees
    4.06K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org